Increased Risk of Renal Deterioration Associated with Low E-GFR in Type 2 Diabetes Mellitus Only in Albuminuric Subjects
Overview
Affiliations
Objective: The significance of estimated glomerular filtration rate (e-GFR) in diabetic nephropathy has yet to be clearly determined. We therefore compared albuminuria and e-GFR for usefulness in predicting progressive decline in renal function.
Methods: A total of 1,303 subjects with type 2 diabetes mellitus whose e-GFR was more than 30 mL/min/1.73 m(2) were followed for three years. Associations of clinical staging based on AER and that based on e-GFR with progression of renal insufficiency (e-GFR <30 mL/min/1.73 m(2)) were evaluated.
Results: On univariate analysis, both clinical stages based on e-GFR and AER were significant variables (p<0.05). On multiple logistic regression analysis, the odds ratio for macroalbuminuria was 132.3, and that for microalbuminuria was 10.3 while that for e-GFR less than 60 mL/min/1.73 m(2) was 9.0 for further deterioration of renal function. On the other hand, subjects without albuminuria exhibited a rate of disease progression of less than 1% irrespective of e-GFR level.
Conclusions: Both albuminuria and reduced e-GFR are significant and independent risk factors for further deterioration of diabetic nephropathy, though albuminuria had a greater odds ratio than reduced e-GFR for deterioration of renal function over a three-year period. e-GFR exhibited additive risk for deterioration of diabetic nephropathy within three years only when albuminuria was present.
Watanabe M, Meguro S, Kimura K, Furukoshi M, Masuda T, Enomoto M J Diabetes Investig. 2024; 16(1):93-99.
PMID: 39539021 PMC: 11693562. DOI: 10.1111/jdi.14309.
Neelamegam V, Surya R, Venkatakrishnan P, Sharma T, Raman R Indian J Ophthalmol. 2024; 72(7):968-975.
PMID: 38454846 PMC: 11329835. DOI: 10.4103/IJO.IJO_2558_23.
CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes.
Daniel Mullins C, Pantalone K, Betts K, Song J, Wu A, Chen Y Kidney Med. 2022; 4(11):100532.
PMID: 36339666 PMC: 9630787. DOI: 10.1016/j.xkme.2022.100532.
Le H, Le T, Tran N, Nguyen T, Minh N, Le Q Healthcare (Basel). 2021; 9(10).
PMID: 34683020 PMC: 8544513. DOI: 10.3390/healthcare9101341.
Meguro S, Inaishi J, Sato Y, Komuro I, Itoh H J Diabetes Investig. 2020; 12(7):1212-1219.
PMID: 33277819 PMC: 8264407. DOI: 10.1111/jdi.13474.